Pathological gamblers needed as volunteers for study

The Department of Psychiatry and Behavioral Sciences is looking for people who are suffering from pathological gambling to participate in a double-blind study. More than 98,000 people in the Bay Area suffer from this impulse control disorder.

Lorrin Koran, MD, a clinical professor in the department, will test the safety and efficacy of Topiramate as treatment for pathological gambling. The U.S. Food and Drug Administration has already approved the medication for the treatment of epilepsy and migraine, but not for pathological gambling.

To be eligible for the study, volunteers must be between the ages of 18 and 70, willing to be interviewed in the clinic a minimum of 11 times over 16 weeks and meet criteria for pathological gambling. Participants must not be abusing alcohol or recreational drugs. The study is being funded by Johnson & Johnson, which makes Topiramate. For more information, please contact Emily Smith, clinical research coordinator, at 498-5644 or 725-5180.